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a b s t r a c t
INTRODUCTION: Primary malignant melanoma of the esophagus is a rare diagnosis with only a few hun-
dred cases reported in the literature. Due to the aggressive nature of this disease, long-term survivors
are exceedingly rare with only a handful of case reports.
PRESENTATION OF CASE:We report the case of a 38 year old man who presented with chest and back pain.
Workup revealed a mediastinal mass and the patient was diagnosed with primary malignant melanoma
of the esophagus and treated with radical resection. Despite the poor prognosis associated with primary
malignant melanoma of the esophagus, he remains disease free for over 7 years.
DISCUSSION: Initially primary malignant melanoma of the esophagus was a controversial diagnosis until
the demonstration of normal melanocytes in healthy patients. It is an aggressive disease that is nearly
uniformly fatal. Review of the literature shows that treatment with radical surgical resection extends
prognosis by months while treatment with adjuvant chemotherapy is controversial.
CONCLUSION: Primary malignant melanoma of the esophagus is a rare and aggressive disease that should
be treated with surgical resection when feasible. We report the rare case of a long term survivor over 7
years since diagnosis.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Case presentation
An athletic 38 year old African American gentleman presented
to the emergency room after a bout of “food poisoning” with chest
pain and back discomfort. The workup included a chest X-ray
(Fig. 1) revealing a mediastinal mass. Upon further questioning the
patient denied any history of hematemesis, melena, dysphagia, or
weight loss. His family history was notable for colon cancer in his
mother. Physical examwas unremarkable for a palpable abdominal
mass or any suspicious skin lesions.
He underwent a computed tomography (CT) scan which
showed a large posterior mediastinal mass measuring
9.4 cm×7.8 cm×8.4 cm extending laterally from the esopha-
gus and compressing the left lower lobe of the lung at the level of
T8–T11 (Fig. 2). There were no other lesions or masses identiﬁed,
no lymphadenopathy, and no free ﬂuid. An esophageal contrast
study showed extrinsic compression of the posterior esophagus
with no mucosal lesion (Fig. 3). Endoscopic ultrasound was con-
Abbreviations: PMME, primarymalignantmelanoma of the esophagus; CT, com-
puted tomography; PET, positron emission tomography.
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sistent with a submucosal lesion without mucosal involvement.
An adjacent lymph node at 47 cm was observed, when biopsied
was consistent with malignant melanoma. Further workup with
ﬂuoro-deoxyglucose–positron emission tomography (FDG–PET),
magnetic resonance imaging of the brain, and fundoscopic
exams showed no evidence of distant disease. Resection was
recommended.
At the time of operation a video-assisted thoracoscopy was
performed to rule out gross dissemination, which would make
resection futile. The tumor was observed to extend directly from
the esophagus to the left lower lobe at the ﬁssure but appeared
resectable (Fig. 4). A thoracoabdominal approach was performed
from the sixth interspace. The esophagus and stomach were mobi-
lized and the Kocher maneuver was carried out with dissection
across the hiatus into the lower chest freeing up the tumor with
the attached portion of the lower lobe. A left lower lobectomy was
then performed to be included en bloc with the esophagus. The
proximal esophagus was divided and the stomach tubularized. A
pyloroplasty was performed and the gastric conduit anastamosed
to the proximal esophagus using an end to end anastomosis stapler.
Pathology of the specimen revealed a malignant melanoma, cir-
cumscribed, bordering the esophageal adventitia and the pleura of
the left lower lobe (Fig. 5). Incidentally found was a CD 117 positive
gastrointestinal tumor of the stomach.
http://dx.doi.org/10.1016/j.ijscr.2014.12.016
2210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Fig. 1. Conventional chest X-ray showing a mediastinal mass superimposed on the
left heart.
The patient had an uneventful hospital course and was dis-
charged home. He has subsequently undergone regular CT and
PET–CT scans and remains disease free for over 7 years.
2. Discussion
Primarymalignantmelanomaof the esophagus (PMME) is a rare
diagnosis. Theﬁrst described casewasbyBaur [1] in1906, and since
thenapproximately340havebeen reported in the literature [2]. Ina
recently published series of 910 esophageal biopsies in Japan, only
2 were found to be melanoma (0.2%) [3]. This is consistent with
previously published data in which PMME accounted for 0.1–0.2%
ofmalignant esophageal lesions [4]. The average age of onset is 60.5
years with a male to female ratio of 2:1 [2].
In 1964 Das Gupta and Brasﬁeld [5] demonstrated that malig-
nant melanoma metastasized to the esophagus in 4% of autopsies
of patientswhohaddied ofmelanoma arising fromcutaneous sites.
It was not until 1963 that typical melanocytes were demonstrated
in the esophagus in 4% of cadavers who did not die of malig-
Fig. 3. Barium swallow study showing extrinsic compression of the esophagus. The
mediastinal mass is again demonstrated.
nant melanoma [6]. Until then, typical melanocytes had not been
described in the esophagus, so a diagnosis of PMME was contro-
versial. Melanocytosis of the esophagus, sometimes a consequence
of chronic esophagitis, may be a precursor of PMME. There is at
least one documented case of PMME arising from localized benign
melanocytosis [7].
Regardless of the pathophysiology, the prognosis of PMME is
very poor and with few exceptions is uniformly fatal. Sabanathan
et al. reported an overall survival of 9.8 months, 14.2 months
for radical resections and 9 months after limited local resection
[4]. Of the patients undergoing palliative or therapeutic resection,
they reported a 5-year survival rate of 4% for patients undergoing
surgery in a series of 139patients.More recently, Volpin et al. calcu-
latedan improved5-year survival rateof37% ina review25patients
undergoing surgical resectionbasedon the literaturebetween1989
and 2000. Death occurred in the ﬁrst postoperative year in 77% of
those patients [8].
Fig. 2. Computed tomography showing transverse (left) and coronal (right) sections through the tumor.
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Fig. 4. VATS image of clamp displacing mass revealing inﬂammatory adhesions to
the pericardium.
Fig. 5. Photomicrograph showing diffuse sheets of atypical cells with dark brown
pigments in the background. (Hematoxylin and eosin×200). Inset shows pleo-
mophic cells with abundant eosinophilic cytoplasm (Hematoxylin and eosin×400).
Reports of long-term survivors are still rare, however. Radi-
cal excision extends mean survival to just over a year, and the
role for chemotherapy and interferon therapy is unclear. There
are ﬁve reports of patients surviving more than 7 years, several
of whom had chemotherapy in addition to surgical resection. In
2004, Uetsuka et al. [9] reported a disease-free 8-year survivorwho
underwent sub-total esophagectomy and proximal gastrectomy
after two weeks of preoperative chemotherapy with dacarbazine,
nimustine, cisplatin, and tamoxifen, which resulted in shrinkage
of the tumor by approximately 30%. The patient also underwent
post-operative chemotherapywith 12 courses of the same regimen
and continued on daily tamoxifen and monthly interferon-beta
injections [9]. In 2007, Kawada et al. [10] reported another 7-
year survivor who underwent a similar treatment with 1 course of
pre-operative and 9 courses of post-operative therapy with dacar-
bazine, nimustine, and vincristine. In addition to postoperative
injections, interferon betawas injected preoperatively directly into
the tumor. Tamoxifen was not used in this case. In a third case, a
patient treated with resection alone was found to have metasta-
sis to a supraclavicular lymph node 30 months after surgery and
treated with radiation and 5-ﬂuoro uracil [11]. This patient went
on to be disease-free for at least 9 years after the original operation.
Itami et al. [12] report a woman who was alive and disease free
11 years after resection of PMME. She received neoadjuvant and
adjuvant cisplatin. Interestingly, the longest reported survivor had
positive lymph nodes and did not receive chemotherapy as Hamdy
et al. [13] reported a woman who had a large 12 cm esophageal
melanoma with positive lymph nodes found at the time of surgery.
She was treated with surgical resection alone and despite positive
nodes she was disease-free for at least 12 years.
The patient we report here did not receive chemotherapy but is
a long-term survivor who has been disease-free for 7 years. While
the role of chemotherapy and interferon therapy is unclear, radical
surgical resection of PMME offers the opportunity for long-term
survival despite a poor overall prognosis.
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